Effect of solvent and temperature on solution-crystallized terfenadine

The aim of this work was to understand the crystallization process of terfenadine in solution.Cooling of saturated solutions prepared at 50 °C at different temperatures, evaporating the solvent from nearly saturated solutions at a certain temperature, and exposing ethanol solutions of terfenadine to water vapour atmosphere were the techniques used for obtaining terfenadine specimens. The characterization of these specimens was carried out by thermal microscopy, differential thermal analysis, thermogravimetry and powder X-ray diffraction. Crystalline phases, amorphous solids, and solvates were identified. For the solvents used in the present study, the crystallinity degree of terfenadine decreases from ethanol-water to ethanol and from this to methanol. Decreasing the temperature promotes the formation of amorphous solid material; at low temperatures, methanol and ethanol solvates are also formed.Desolvation, following the terfenadine aggregation process in solution accounts for the different behaviour found for the solvents and for the effect of temperature on the structure. The role of the solvent as structure-mediator is explained on the grounds of the values previously published for the enthalpy of solution of terfenadine in the solvents under study.     

Enantioselective Analyses of Antihistaminic Drugs by High-Performance Liquid Chromatography

High-performance liquid chromatographic methods have been developed for stereoselective separations of terfenadine and its active metabolite fexofenadine. Satisfactory enantioseparations of racemic terfenadine were achieved on a Chiralcel column by normal phase elution. Analysis of racemic fexofenadine, as such, took a very long time and achieved poor enantioselectivity on this column; nevertheless, the analyte when derivatised with diazomethane was well resolved. Racemic fexofenadine was also derivatised using a chiral agent: R-(+)-1-phenylethylisocyanate and subjected to achiral LC on a reversed-phase analytical column. Complete enantioseparations were achieved in short analysis times; excess reagent eluted before the diastereoisomeric pair and did not interfere.Part of this work was presented at the 10^th International Meeting on Recent Developments in Pharmaceutical Analysis RDPA03, Cogne, Valle d Aosta, Italy. June 28–July 1, 2003.     

The terfenadine/β-cyclodextrin inclusion complex

Terfenatine (TFN) is a very hydrophobic antiallergic drug. It exists in three polymorphic and two solvated forms and is practically insoluble in water. These properties make a pharmaceutical formulation with acceptable biopharmaceutical characteristics difficult to prepare. Inclusion complexation with -cyclodextrin (CD) may eliminate such problems. The properties of the TFN/CD system have been studied in liquid, gaseous and solid phases by¹H and¹³C NMR spectroscopy, powder X-ray diffractometry, differential scanning calorimetry and fast atom bombardment mass spectrometry. The solubility phase diagram was also recorded. In solution and in the gaseous phase the 11 complex prevails, whereas a 12 TFN/CD complex has been isolated by precipitation from homogeneous solution.     

The glycan patterns at the individual glycosylation sites in orosomucoid from allergic reaction patients

Summary Little is known about the alterations that have occurred at the individual glycosylation sites in allergy patients or how these glycosylation patterns may change after anti-allergy treatments. Using reverse-phase HPLC, we have quantitated the glycoforms present at the individual glycosylation sites on orosomucoid isolated from the sera of allergic reaction patients and an allergic reaction patient treated with the antihistamine Terfenadine. The glycan structures isolated from the five glycosylation sites for the individual taking Terfenadine were all within normal ranges. It is suggested that if the changes in glycosylation in OMD in the allergic state are functionally driven, then it should be possible to correlate biological activities with quantitative changes at the individual glycosylation sites, and hence further define the role of OMD in allergy and inflammation.     

Spectrophotometric determination of terfenadine in pharmaceutical preparations by charge-transfer reactions

A simple, rapid and accurate method for the spectrophotometric determination of terfenadine has been developed. The proposed method based on the charge-transfer reactions of terfenadine, as n-electron donor, with 7,7,8,8-tetracyanoquinodimethane (TCNQ), tetracyanoethylene (TCNE), 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) or 2,5-dichloro-3,6-dihydroxy-1,4-benzoquinone (chloranilic acid, p-CLA) as π-acceptors to give highly colored complexes. The experimental conditions such as reagent concentration, reaction solvent and time have been carefully optimized to achieve the highest sensitivity. Beer's law is obeyed over the concentration ranges of 3–72, 3–96, 12–168 and 24–240 μg mL⁻¹ terfenadine using TCNQ, TCNE, DDQ and p-CLA, respectively, with correlation coefficients 0.9999, 0.9974, 0.9997 and 0.9979 and detection limits 0.3, 0.4, 2.6 and 12.3 μg mL⁻¹, for the reagents in the same order. DDQ and p-CLA react spontaneously with terfenadine to give colored complexes that can be applied for the flow injection analysis of terfenadine in the concentration ranges 2.4–120 and 24–240 μg with correlation coefficients 0.9990 and 0.9985 and detection limits 0.8 and 2.7 μg for DDQ and p-CLA, respectively, in addition to the high sampling through output of 40 sample h⁻¹.     

疏水性L-酒石酸酯萃取分离特非那丁对映体

研究了特非那丁对映体在含有疏水性L-酒石酸酯的1,2二氯乙烷溶液及甲醇水溶液两相中的萃取分配行为,考察了不同烷基链长的L-酒石酸酯,L-酒石酸酯的浓度,有机溶剂的种类,及其溶解特非那丁的甲醇水溶液浓度对分配系数K和分离因子α的影响。实验表明:L-酒石酸酯与特非那丁Ⅱ对映体形成的复合物稳定性比与特非那丁Ⅰ对映体形成的复合物稳定性要大,三类有机溶剂的萃取性能为醇>1,2二氯乙烷>烷烃;甲醇的浓度在50%~90%时,随着溶解特非那丁的甲醇水溶液中的甲醇浓度的增加,分配系数和分离因子均降低;当甲醇的浓度为50%时,可以得到最佳的K和α;随着L-酒石酸酯的浓度的提高,分配系数K和α分离因子先增加然后减小;当L-酒石酸酯的浓度约为0.25 mol/L时,K和α达到最大值;L-酒石酸酯的碳链长度对分配系数K和分离因子α也有很大的影响。     

Solubilization of Terfenadine,Riboflavin, and Sudan III by Aqueous Multi-basic Organic Acids

ABSTRACT

The aqueous solubility of terfenadine, riboflavin, and Sudan III (water-insoluble compounds) was enhanced by the addition of multi-basic organic acids, including citric, glutaric, malic, malonic, and tartaric acids. The variations of physical properties (density, viscosity, electrical conductivity, pH, and surface tension) against acid concentration (0–3.6 M at 25°C) were measured in order to explore possible mechanisms of solubility enhancement. Apart from the partial molar volumes, the measured physical properties varied nonlinearly with acid concentration. Glutaric acid contributes to solubility enhancement of terfenadine and Sudan III more than citric acid, with the latter slightly more effective towards riboflavin. Tartaric acid is the least effective, while malic and malonic acids occupy an intermediate position. Among the organic acids examined, only glutaric acid solutions exhibit significant surface activity, which lends itself to solubility enhancement of the three hydrophobic drugs (interfacial packing of 55 ± 3 Å² at the air–water interface, critical aggregate concentrations (CAC) at 1.8 ± 0.4 M). In contrast, all five organic acid solutions of terfenadine demonstrate more effective lowering of the surface tension of water, with the terfenadinium acid salts exhibiting interfacial packing of 108 ± 9 Å² at the air–water interface. On the other hand, organic acid solutions of riboflavin and Sudan III exhibited essentially no surface activity, aside from the intrinsic contribution of the organic acids themselves. Thus, self-association of glutaric acid contributes to the solubility enhancement of the three hydrophobic drugs. This combined with the surface activity of terfenadinium acid salts explains the higher tendency of glutaric acid to solubilize terfenadine. Mixed micellization of terfenadinium glutarate and glutaric acid occurs with an interfacial packing of 166 ± 18 Å² at the air–water interface. The corresponding CAC were estimated at 3.1 ± 0.2 mM for terfenadinium glutarate and 8.0 ± 0.4 mM for glutaric acid. Intermolecular hydrogen bonding with the extensive hydroxyl group network of riboflavin reflects the higher affinity of citric acid than glutaric acid towards riboflavin. The variability in solubility enhancement exhibited by tartaric, malic, and malonic acids appears to be a result of the interplay between several factors including intra- vs. inter-molecular hydrogen bonding, slight organic acid surface activity, and acid hydration.     

Evaluation of the physical stability and local crystallization of amorphous terfenadine using XRD-DSC and micro-TA

It is very difficult to follow rapid changes in polymorphic transformation and crystallization and to estimate the species recrystallized from the amorphous form. The aim of this study was to clarify the structural changes of amorphous terfenadine and to evaluate the polymorphs crystallized from amorphous samples using XRD-DSC and an atomic force microscope with a thermal probe (micro-TA). Amorphous samples were prepared by grinding or rapid cooling of the melt. The rapid structural transitions of samples were followed by the XRD-DSC system. On the DSC trace of the quenched terfenadine, two exotherms were observed, while only one exothermic peak was observed in the DSC scan of a ground sample. From the in situ data obtained by the XRD-DSC system, the stable form of terfenadine was recrystallized during heating of the ground amorphous sample, whereas the metastable form was recrystallized from the quenched amorphous sample and the crystallized polymorph changed to the stable form. Obtained data suggested that recrystallized species could be related to the homogeneity of samples. When the stored sample surface was scanned by atomic force microscopy (AFM), heterogeneous crystallization was observed. By using micro-TA, melting temperatures at various points were measured, and polymorph forms I and II were crystallized in each region. The percentages of the crystallized form I stored at 120 and 135 °C were 47 and 79%, respectively. This result suggested that increasing the storage temperature increased the crystallization of form I, the stable form, confirming the temperature dependency of the crystallized form. The crystallization behavior of amorphous drug was affected by the annealing temperature. Micro-TA would be useful for detecting the inhomogeneities in polymorphs crystallized from amorphous drug.